test

Robert J. Wenzel

@Aisling Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$261.072MTotal holdings16
Assets growth rate13%Assets growth rate (2-Q avg)-4.4%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Aisling Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 16 positions.

Assets under management

The assets under management (AUM) of Aisling Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 261.072M in assets, with a quarterly growth rate of 13% and a 2-quarter average growth rate of -4.4%. The portfolio is managed by Robert J. Wenzel, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CALCCalcimedica, Inc. (calc)
Recent Activity
0.89%
$2.309M
521,114 shares@ $4.43 avg price
ELEVElevation Oncology Inc (elev)
Recent Activity
0.66%
$1.701M
2.835M shares@ $0.6 avg price
RPHMReneo Pharmaceuticals Inc (rphm)
Recent Activity
0.58%
$1.506M
886,075 shares@ $1.71 avg price
MRKRMarker Therapeutics, Inc. (mrkr)
Recent Activity
0.34%
$886,286
314,286 shares@ $2.82 avg price
ACRSAclaris Therapeutics Inc (acrs)
Recent Activity
0.2%
$499,623
434,455 shares@ $1.15 avg price
VIRXViracta Therapeutics Inc (virx)
Recent Activity
0.03%
$66,371
288,571 shares@ $0.23 avg price